Benzinga | Aug 26, 2021 07:06AM EDT

Redhill Biopharma Q2 EPS $(0.06) Beats $(0.12) Estimate, Sales $21.50M Miss $25.02M Estimate

Redhill Biopharma (NASDAQ:RDHL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.12) by 50 percent. This is a 250 percent decrease over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $21.50 million which missed the analyst consensus estimate of $25.02 million by 14.07 percent. This is a 2.88 percent increase over sales of $20.90 million the same period last year.